Power Law company profile

Inhibrx

Biotech & Life Sciences · San Diego, United States · Founded 2017 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.81B

Market cap · Apr/2026

Revenue

$1.3M

Latest reported FY

Investors

6 investors on Inhibrx's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 6 investors entered at this stage

Lilly Asia Ventures

RA Capital Management

Perceptive Advisors

ArrowMark Partners

TCGX

Viking Global Investors

Global footprint

Where Inhibrx has talent and traffic

Web traffic by country

4.1K monthly visits
across markets

🇺🇸 United States73.2%

🇵🇭 Philippines17.1%

🇮🇳 India7.3%

Top 3 markets shown

Patent intelligence

$237M patent portfolio · 107 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$237M

13.1% of market cap · 8.5× smaller than top peer Ablynx ($2B)

107 active patent families

Where Inhibrx innovates Molecular biologyCell biologyBiochemistryFusion proteinCarcinosis

Above peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

Inhibrx on the five Patsnap quality dimensions

Inhibrx in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Inhibrx concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Inhibrx and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Inhibrx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo